IVF PulseFree Second Opinion

Repeated IVF failure; recurrent implantation failure (RIF)

Repeated IVF failure: when it counts as RIF and what testing is justified

The short answer

Several failed cycles are not automatically a diagnosis. ESHRE's 2023 recommendations call it recurrent implantation failure only once your predicted cumulative chance of implantation has passed 60% 1. In a UK study, the chance of a baby within each cycle stayed above 20% up to the fourth cycle for women under 40, but was far lower after 40 2.

You have been through two, three or more cycles, and none has ended with a baby. The questions are different now. Is something wrong that nobody has found? Is it still worth going on? When does it make sense to think about donor eggs, a break, or stopping?

This page is about the whole run of cycles, not a single transfer. It covers how ESHRE now defines repeated failure, what the largest study of repeat IVF found about the odds at each cycle number, which tests have evidence at this stage and which are sold without it, and how people weigh continuing, donor eggs, a break or stopping. The test-by-test detail for failed transfers is on the implantation failure page.

How common is this?

22.6%

Live birth within the third cycle (one egg collection plus all its fresh and frozen transfers), all women who had a third cycle, UK 2003–20102

21.4%

Live birth within the fourth cycle, women under 40 using their own eggs2

7.8%

Live birth within the fourth cycle, women aged 40–42 using their own eggs2

Under 4%

Live birth within any cycle, women over 42 using their own eggs2

29.6% or more

Live birth within each cycle up to the ninth, women of any age using donor eggs2

2.5%

Live birth per cycle among women aged 35 and over after four failed cycles within 12 months, own eggs, fresh transfers, Israeli health-system data3

Reading your report

Cycle (in cumulative figures)
In the UK study used on this page, one round of stimulation and egg collection plus every fresh and frozen transfer from it 2. Two frozen transfers from one collection count as one cycle.
Cumulative live birth rate
The chance of having had a baby by the end of a given number of cycles, as opposed to the chance within any one cycle.
Recurrent implantation failure (RIF)
ESHRE's term for transfers of embryos thought to be viable failing to give a positive pregnancy test often enough, for your particular odds, to justify looking for a cause 1.
Cumulative predicted chance of implantation
A running total of the estimated chance from each transfer so far. ESHRE says it should at least take account of age, the number and stage of embryos transferred, and how many were chromosomally normal if they were tested 1.
Prognosis-adjusted estimate
A cumulative figure that assumes 30% of the women who stopped treatment did so because their chances were poor 2. It sits between a pessimistic and an optimistic estimate.
Donor oocytes
Eggs from another woman. In India they must come through a registered ART bank, from a donor aged 23 to 35 9.

Likely causes, most common first

CauseHow you'd knowTest that tells you
Chromosome errors in the embryos, which rise with ageYour age at each egg collection. In the UK data, first-cycle live birth was 32.3% under 40 and 12.3% at 40–42 with own eggs 2PGT-A in a future cycle: ESHRE says it can be considered in RIF 1; the HFEA rates it red for the chance of a baby 4
Chance, if you have not yet passed ESHRE's thresholdYour doctor estimates your cumulative predicted chance so far and it is below 60% 1None; ESHRE advises simply proceeding to another cycle 1
Few eggs in each collectionLow counts across cycles. For women under 40, live birth rose with the number of eggs collected up to about 15, then levelled off 2A review of how stimulation was planned in each cycle
A problem in the uterine cavity or a fluid-filled tubeSeen on transvaginal or 3D ultrasound, or at hysteroscopy3D ultrasound, hysteroscopy or tubal imaging (ESHRE: can be considered) 1
Untreated male-factor infertilitySemen results. Rates were lower with untreated male factor, and ICSI or donor sperm removed the difference 2Semen analysis and a review of whether ICSI was used 2
A balanced chromosome change in either partnerKaryotype blood test. Found in about 2.1% of RIF patients in the studies ESHRE reviewed 1Karyotyping both partners (ESHRE: can be considered) 1
Antiphospholipid syndromePast blood clots or recurrent miscarriage. Found in 2.88% of 185 RIF patients in one study 1Antiphospholipid antibody tests (ESHRE: recommended if you have extra risk factors) 1

What did not cause this

  • "Stress over all these cycles is what stopped them working"

    A BMJ meta-analysis of 14 studies (3,583 women) found emotional distress before treatment was not associated with whether a cycle led to pregnancy 8.

  • "My body keeps rejecting the embryos"

    ESHRE does not recommend NK cell, T-cell or cytokine tests for RIF 1. Its add-ons group notes that uterine NK cells are only weakly able to kill cells and cannot kill placental cells 5.

  • "If there were a reason, the tests would have found it"

    ESHRE says much is still unknown about implantation failure and asks clinics to be honest that many tests and treatments offered for it lack evidence of benefit 1. A normal workup is a real result.

  • "Thinking about stopping means I didn't try hard enough"

    In a review of 22 studies (21,453 patients), the physical and psychological burden of treatment was among the most common reasons people gave for stopping 7. The HFEA says every couple is different and some move on from treatment earlier than others 6.

Do two or three failed IVF cycles count as recurrent implantation failure?

Not by a fixed count. Older definitions called it RIF after two or three transfers of good-quality embryos 1. ESHRE's 2023 recommendations dropped the fixed count because it ignores your individual odds. They define RIF as transfers failing often enough, given your chances, to justify investigation, and set the trigger at a 60% cumulative predicted chance of implantation 1. Below that, ESHRE advises simply going ahead with another cycle 1.

Two things follow. First, RIF is about transfers. Cycles that stopped earlier, with no eggs, no fertilisation or no embryos to transfer, are a different problem, and the stage where each stopped points to the cause. Second, the count depends heavily on age and on whether embryos were chromosomally tested. The implantation failure page shows how the threshold is worked out transfer by transfer.

What are the chances of IVF working after several failed cycles?

The best data on repeat cycles come from a UK study of 156,947 women and 257,398 cycles started between 2003 and 2010 2. Across all women, the chance of a baby within each cycle was 29.5% in the first, 24.9% in the second, 22.6% in the third, 20.5% in the fourth and 17.4% in the sixth 2. Each new cycle carried a somewhat lower chance, but not a collapse.

Added up, the prognosis-adjusted cumulative rate for women under 40 using their own eggs was 58.0% by the third cycle and 68.4% by the sixth 2. Those five or six cycles took time: for women under 40, five cycles took a median of 2 years 2.

Age matters more than the number of failures. For women over 42 using their own eggs, the rate within every cycle was under 4%, and the cumulative rate did not clearly rise beyond the fourth or fifth cycle 2. Women using donor eggs had rates of 29.6% or more within each cycle whatever their age 2.

Read these figures with care. They are UK results from 2003–2010, when 78.0% of transfers in first cycles used two embryos 2; Indian law now allows no more than three embryos in a cycle 9. Only 1,162 women reached a sixth cycle 2. Ask your clinic for its own figures for your age.

Which tests are worth doing after repeated failure, and which are sold without evidence?

After several failed transfers the list of tests on offer tends to grow. ESHRE sorted them into recommended, can be considered and not recommended 1. Most of the long lists sold after repeated failure fall in the last group.

  • Evidence-backed or reasonable to consider: a review of lifestyle factors in both partners; re-measuring the lining if it has been thin; antiphospholipid antibodies if you have clotting risk factors; karyotypes of both partners; 3D ultrasound or hysteroscopy if the cavity is in doubt; thyroid function 1.
  • Hysteroscopy for everyone: in the TROPHY trial of 702 women with two to four failed IVF cycles and no known uterine problem, live birth was 29% with and 29% without it 1.
  • PGT-A: ESHRE says it can be considered in RIF 1, but the HFEA rates it red for the chance of a baby for most patients 4. It chooses among embryos you already have; it cannot make more.
  • Sold but unproven: NK cell tests, uterine T-cell and cytokine tests, HLA-C matching, microbiome profiling and sperm DNA fragmentation testing are not recommended by ESHRE for RIF 1.
  • Sold but unproven: endometrial receptivity tests such as ERA are not recommended by ESHRE's add-ons group 5, and the HFEA rates them red 4.
  • Sold but unproven: intralipid, IVIG, G-CSF, intrauterine PRP, and heparin without diagnosed antiphospholipid syndrome are not recommended by ESHRE for RIF 1; ESHRE's add-ons group does not recommend steroids in IVF 5; the HFEA rates IVIG, steroids and PRP red and intralipids grey 4.

When should you think about donor eggs?

Donor eggs make most sense when age or egg numbers are the main problem. In the UK data, using donor eggs removed the age difference in live birth, and women using them had rates of 29.6% or more within each cycle up to the ninth 2. For women over 42 using their own eggs, every cycle was under 4% 2.

When the cause is unexplained, the case is less certain. ESHRE says moving to donor eggs or sperm could bypass an unidentified problem with the eggs, sperm or embryo, but that studies are still needed to confirm it improves the chance of a baby after RIF 1. It also notes that donation brings its own challenges and needs support and clear information 1.

In India, the ART (Regulation) Act, 2021 requires donor eggs to come through a registered ART bank, from a donor aged 23 to 35 who donates once in her life, with no more than seven eggs retrieved and no donor's eggs supplied to more than one couple 9. Donor embryos are less clear. The ART Rules, 2022 say unused embryos are to be kept for the same recipient and not used for any other couple 10. Ask your clinic how this applies before planning around donor embryos.

When is it reasonable to take a break or stop?

There is no number of cycles after which stopping becomes correct. The HFEA suggests asking your doctor for an honest opinion on whether treatment may work for you, and weighing a very small chance of success, and the emotional burden on you and your partner, in the decision 6. ESHRE asks clinicians to be honest about likely outcomes and avoid false reassurance 1.

Some evidence helps frame that conversation. In an Israeli study of 16,299 women, those aged 35 and over who had four failed cycles within 12 months had a live birth rate of 2.51% per further cycle, against 15.61% for women with at least four failures who had not had four within one year 3. The authors suggest this pattern may support counselling about continuing with own eggs or moving to other options 3. It was a retrospective study in one health system, covering only fresh transfers 3.

A break is also a choice, not a failure. The HFEA advises giving yourself time to come to terms with a negative result and to let your body recover, and suggests an impartial counsellor if you and your partner disagree about continuing 6.

What does repeated failure cost, emotionally and financially?

ESHRE's RIF document notes that women with RIF report higher stress than fertile women, along with social isolation and sensitivity to comments, and that hope was lower in people after repeated cycles than in those starting a first 1. It says psychosocial care should be offered before, during and after treatment 1. No information was available on male partners 1.

On money, the HFEA points out that if you are paying for treatment yourself, it may be better to pay for further cycles of proven treatment than to spend large sums on add-ons that have not been shown to work 4. Under the ART Act, clinics must tell you the cost of procedures as well as their advantages, disadvantages and risks 9. We have not found a reliable published figure for the total cost of repeated IVF in India, so none is given here.

It depends on…

Did your cycles fail at transfer, or earlier?

Embryos were transferred each time, but none implanted

This is where ESHRE's RIF definition applies. Ask whether you have passed the 60% threshold 1.

Cycles stopped earlier: few or no eggs, no fertilisation, or no embryos to transfer

RIF does not describe this. The stage where each cycle stopped points to the likely cause; the stage guides cover each one.

Positive tests that were followed by losses

That is pregnancy loss rather than implantation failure. The chemical pregnancy and miscarriage pages cover the workup.

How old were you at the egg collections?

Under 40

In UK data, live birth within the fourth cycle was still 21.4% with own eggs 2.

40 to 42

Live birth within the fourth cycle was 7.8% with own eggs 2. Ask what your own chance per cycle is.

Over 42

Under 4% within every cycle with own eggs; donor eggs removed the age difference 2.

Can you manage more cycles, emotionally and financially?

Yes

Ask for an estimate of your chance in the next cycle and what, if anything, will change 6.

Not sure, or no

A break or stopping is a legitimate choice. The HFEA suggests weighing the chance of success against the emotional burden, with a counsellor if that helps 6.

Chance of a baby within each cycle, by age (UK, own eggs, 2003–2010)

CycleUnder 4040–42Over 42
1st32.3% 212.3% 23.7% 2
2nd27.1% 210.1% 23.3% 2
3rd24.3% 28.6% 23.3% 2
4th21.4% 27.8% 2Too few births to estimate 2
5th19.0% 25.3% 2Too few births to estimate 2
6th17.0% 26.9% 2Too few births to estimate 2

What's worth checking

  • List every cycle: date, your age at egg collection, eggs, embryos, number and day of each transfer, whether tested, and the result.
  • Mark which cycles reached a transfer and which stopped earlier; only failed transfers count towards RIF 1.
  • Ask your doctor for your cumulative predicted chance of implantation so far, against ESHRE's 60% threshold 1.
  • Ask for your clinic's own live birth rate per cycle for your age group; ESHRE says a centre's own data can be used 1.
  • Check whether your uterine cavity has been imaged and whether both partners have had a karyotype 1.
  • If there is a male factor, check whether ICSI or donor sperm was used 2.
  • Before paying for any add-on, look up its HFEA rating 4.
  • Talk together about how many more cycles, and what cost, you are prepared for; the HFEA suggests a counsellor if you disagree 6.

What could change next cycle

7 options, by strength of evidence

  • Good evidence it helps 1
  • Mixed, or some groups only 3
  • Not enough studies yet 1
  • Evidence says it doesn't help 2

Ratings follow the evidence reviews cited beside each option, not our opinion.

  • Another cycle with the same approach, if you are below ESHRE's threshold or nothing specific was foundGood evidence it helps

    ESHRE advises proceeding below its threshold 1; within-cycle live birth stayed above 20% to the fourth cycle for women under 40 in UK data 2.

  • Donor eggsMixed, or some groups only

    Removed the age difference in UK data 2; ESHRE says studies are still needed to confirm benefit after unexplained RIF 1.

  • Karyotyping, with genetic counselling and PGT if a change is foundMixed, or some groups only

    ESHRE: karyotyping can be considered; counselling and PGT recommended if abnormal; applies to about 2.1% of RIF patients 1.

  • PGT-A (chromosome testing of embryos)Mixed, or some groups only

    ESHRE RIF: can be considered 1. HFEA: red for the chance of a baby for most patients 4.

  • Hysteroscopy when no uterine problem is suspectedEvidence says it doesn't help

    TROPHY trial, two to four failed cycles: 29% live birth with and without it 1.

  • Endometrial receptivity test (ERA)Evidence says it doesn't help

    ESHRE add-ons: not recommended 5. HFEA: red 4.

  • Immune tests and treatments (NK cells, intralipid, IVIG, steroids)Not enough studies yet

    ESHRE: NK cell tests, intralipid and IVIG not recommended in RIF 1; steroids not recommended in IVF 5. HFEA: IVIG and steroids red, intralipids grey 4.

Questions to ask your doctor

  1. How many of my cycles reached a transfer, and what was my cumulative predicted chance of implantation across those transfers 1?
  2. What is this clinic's live birth rate per cycle for women my age, and how many cycles is that based on?
  3. Has anything in my cycles pointed to a specific cause, or is this unexplained?
  4. For each test you suggest, what result would change the next cycle, and is it recommended by ESHRE for RIF?
  5. Given my age and egg numbers, how do my chances with my own eggs compare with donor eggs?
  6. If we go ahead, what will be different this time, and at what point would you advise us to pause?

Questions people ask

How many IVF cycles should I try before giving up?

There is no agreed number. In the UK study, cumulative live birth kept rising up to the ninth cycle for women under 40 and for women using donor eggs, but for women over 42 using their own eggs it did not clearly rise beyond the fourth or fifth 2. ESHRE's 60% threshold is a point to investigate, not a point to stop 1.

Should I try PGT-A after repeated IVF failure?

ESHRE says PGT-A can be considered in RIF, noting retrospective studies in which fewer transfers were needed to reach a pregnancy 1. The HFEA rates it red for improving the chance of a baby for most patients 4. It can help choose among embryos, but it does not increase how many you have.

Can we use donor embryos in India after repeated failure?

The ART Rules, 2022 say a clinic's unused embryos are to be kept for the same recipient and not used for any other couple 10, and section 29 of the ART Act restricts transferring embryos to anyone other than the couple they belong to 9. Ask your clinic, in writing, how the current rules apply before planning around donor embryos.

Does a failed cycle mean the next one will fail too?

Not necessarily. In the UK data, 65.9% of women whose first cycle failed went on to another, and the chance within each later cycle declined gradually rather than dropping to zero, staying above 20% to the fourth cycle for all women 2.

Do donor egg cycles fail too?

Often, yes. In the UK data, women using donor eggs had a live birth within each cycle of 29.6% or more, at every cycle number to the ninth and at every age 2. That is a better and much flatter chance than with own eggs after 40, but it also means most donor-egg cycles in that dataset did not end with a baby 2. Donation changes the odds; it does not remove the possibility of another negative test.

After several failed cycles, is the problem the embryos, my body, or the clinic?

No test separates them, and ESHRE does not claim one dominates. It lists what determines implantation as female factors such as age, hormone levels, endometrial and uterine status and underlying conditions; embryo factors such as cleavage speed, euploidy and whether sibling embryos implanted; male factors; and external factors including the performance of the laboratory and clinic and the transfer policy 1. A model combining all of them does not currently exist 1.

Can I ask my clinic for counselling?

In India it is the clinic's duty, not a favour. The ART (Regulation) Act, 2021 requires clinics to provide professional counselling to the couple and woman about all the implications and chances of success of the procedures in that clinic, and to help them reach an informed decision 9. ESHRE says psychosocial care should be offered before, during and after treatment, and notes hope was lower in people after repeated cycles than in those starting a first 1.

Can we go for surrogacy in India after repeated IVF failure?

Only with a medical indication, and only altruistically. The Surrogacy (Regulation) Act, 2021 allows surrogacy where an intending couple has a medical indication necessitating gestational surrogacy, prohibits commercial surrogacy, and requires a certificate of essentiality that includes a certificate of medical indication from a District Medical Board, plus a magistrate's order on the parentage and custody of the child 11. The Act does not itself list which conditions qualify; further conditions are left to regulations made by the Board 11.

How much should we expect to spend on more cycles?

We have not found a reliable published figure for the cost of repeated IVF in India, so this page does not give one, and a figure quoted without a source is worth questioning. What the law gives you is a right to be told: the ART (Regulation) Act, 2021 requires clinics to inform the couple and woman of the advantages, disadvantages and cost of the procedures, their medical side effects and risks including multiple pregnancy, and to help them reach an informed decision 9. Ask for it in writing.

Why do people stop IVF even when their doctor says they could continue?

Because of what treatment costs them, and not only in money. A systematic review of 22 studies (21,453 patients in eight countries) found the most selected reasons for stopping were postponing treatment (39.18% of selections), the physical and psychological burden (19.07%), relational and personal problems (16.67%), rejecting the treatment itself (13.23%), and organisational or clinic problems (11.68% and 7.71%) 7. No predictor was consistently associated with stopping 7.

Is there any treatment ESHRE actually supports after repeated failure?

Very little, and it says so plainly. Most of the interventions in its 2023 document are 'not recommended', including endometrial scratching, G-CSF, intralipid, IVIG, intrauterine PRP, intrauterine hCG, low molecular weight heparin, GnRH agonist pre-treatment and assisted hatching 1. Blastocyst-stage transfer and PGT-A 'can be considered' 1. For hyaluronic acid-enriched transfer medium, ESHRE cites meta-analyses supporting higher live birth in the general IVF population (OR 1.33) but only one randomised trial in repeated failure 1.

Do these UK figures apply to a clinic in India?

Treat them as a shape, not a quote for your clinic. They come from 156,947 women treated in the UK between 2003 and 2010, when 78.0% of first-cycle transfers used two embryos 2; Indian law now allows no more than three embryos in a cycle 9, and patient mix, practice and laboratory standards differ. Only 1,162 women in that dataset reached a sixth cycle 2. ESHRE says a centre's own data can be used, so ask your clinic for its live birth rate per cycle for your age 1.

Sources

  1. ESHRE Working Group on Recurrent Implantation Failure; Cimadomo D, de los Santos MJ, Griesinger G, Lainas G, Le Clef N, et al. ESHRE good practice recommendations on recurrent implantation failure. Hum Reprod Open. 2023;2023(3):hoad023. ESHRE / Human Reproduction Open
  2. Smith ADAC, Tilling K, Nelson SM, Lawlor DA. Live-birth rate associated with repeat in vitro fertilization treatment cycles. JAMA. 2015;314(24):2654-2662. JAMA
  3. Barkan Y, Wolfson I, Razi T, Abu YB, Netzer D, Arbel R. Live-birth rates after four consecutive failed IVF cycles within one year: a retrospective cohort study of patients aged 35 years and older. Eur J Obstet Gynecol Reprod Biol. 2026;325:115285. European Journal of Obstetrics & Gynecology and Reproductive Biology
  4. Human Fertilisation and Embryology Authority. Treatment add-ons with limited evidence (traffic-light ratings). HFEA (UK regulator)
  5. ESHRE Add-ons Working Group; Lundin K, Bentzen JG, Bozdag G, Ebner T, Harper J, et al. Good practice recommendations on add-ons in reproductive medicine. Hum Reprod. 2023;38(11):2062-2104. ESHRE / Human Reproduction
  6. Human Fertilisation and Embryology Authority. Coping if treatment doesn't work. HFEA (UK regulator)
  7. Gameiro S, Boivin J, Peronace L, Verhaak CM. Why do patients discontinue fertility treatment? A systematic review of reasons and predictors of discontinuation in fertility treatment. Hum Reprod Update. 2012;18(6):652-669. Human Reproduction Update
  8. Boivin J, Griffiths E, Venetis CA. Emotional distress in infertile women and failure of assisted reproductive technologies: meta-analysis of prospective psychosocial studies. BMJ. 2011;342:d223. BMJ
  9. The Assisted Reproductive Technology (Regulation) Act, 2021 (No. 42 of 2021), sections 21(c), 24(b), 27 and 29. Gazette of India Extraordinary, December 2021. Government of India (Gazette of India)
  10. Ministry of Health and Family Welfare (Department of Health Research). Assisted Reproductive Technology (Regulation) Rules, 2022 (G.S.R. 419(E), 7 June 2022), rule 13(1)(a). Government of India, National ART & Surrogacy Portal
  11. The Surrogacy (Regulation) Act, 2021 (No. 47 of 2021), sections 2(b), 2(g), 2(r), 3(ii) and 4(ii)-(iii). Gazette of India Extraordinary, 25 December 2021. Government of India (Gazette of India)

Tools for this step

WhatsApp us